CompletedNot Applicable

Validity and Reliability of the PROprioception Measurement Tool (PROMT)

Switzerland99 participantsStarted 2022-10-01

Plain-language summary

This project assesses the feasibility, reliability, and validity of the PROMT in children with a UMN lesion. The study questions are: is the newly developed PROMT a feasible, reliable, and valid tool to assess lower limb proprioception in children with UMN lesions? Does the PROMT differ between children with UMN lesion and controlled neurotypically developing peers? Further, does the proprioception modalities assessed with the PROMT correlate with motor function in this group of children?

Who can participate

Age range5 Years – 19 Years

SexALL

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion Criteria: * neuromotor impairments due to UMN lesions (diagnoses can be, for example, cerebral palsy (CP), acquired brain injuries, myelomeningocele, hydrocephalus) * ability to sit with or without back support for 30 minutes * ability to stand with or without support * ability to do some steps * informed consent. Exclusion Criteria: * severe visual impairment * surgery within the last six months with involvement of the lower limbs * botulinum toxin injection in the lower limbs within the previous three months * unable to communicate pain or discomfort (verbally or nonverbally) * noncompliance * not able to follow simple short instructions

What they're measuring

Joint Movement Sense

Timeframe: Through study completion, an average of 1 year

Joint position sense

Timeframe: Through study completion, an average of 1 year

Active position sense

Timeframe: Through study completion, an average of 1 year

Trial details

NCT IDNCT05405881

SponsorUniversity Children's Hospital, Zurich

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2023-08-30

View on ClinicalTrials.gov More Child Development trials